import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡ AI æ±ºç­–ç³»çµ± (2026 æœ€çµ‚ä¿®å¾©ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === å…¨åŸŸ UI æ¥µè‡´ç·Šç·»åŒ– === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F8F9FA;
        color: #1A1A1A;
        font-size: 19px !important;
        line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* å¤§éšæ®µæ–¹å¡Šï¼šé«˜åº¦éš¨å…§å®¹æ’é–‹ï¼Œæ¶ˆé™¤é¤˜ç™½ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 2px 10px rgba(0,0,0,0.08);
        border: 2px solid transparent;
        background: white; margin-bottom: 4px; overflow: hidden;
        height: auto !important;
    }
    .big-stage-header {
        font-size: 17px !important; font-weight: 900; color: white;
        padding: 5px; text-align: center; margin: 0 !important;
    }

    /* å­å€å¡Š (SoC)ï¼šæ¥µå°é‚Šè· */
    .sub-block {
        margin: 2px 4px; padding: 4px;
        border-radius: 6px; background: #F1F3F5;
        border-left: 5px solid #546E7A;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #37474F;
        margin-bottom: 1px; border-bottom: 1px solid #CFD8DC; padding-bottom: 1px;
    }
    .sub-block-content {
        font-size: 14px; color: #263238; font-weight: 500; line-height: 1.15;
        margin-bottom: 2px;
    }

    /* éšæ®µé¡è‰²å®šç¾© */
    .card-p-tx { border-color: #2E7D32; }
    .header-p-tx { background: linear-gradient(135deg, #43A047, #2E7D32); }
    .card-p-mt { border-color: #1565C0; }
    .header-p-mt { background: linear-gradient(135deg, #1E88E5, #1565C0); }
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #FB8C00, #E65100); }
    .card-r-mt { border-color: #6A1B9A; }
    .header-r-mt { background: linear-gradient(135deg, #8E24AA, #6A1B9A); }

    /* ç‰¹æ®Šæ¨™ç±¤ */
    .tag-nsmp { color: #6A1B9A; font-weight: 900; }
    .tag-highlight { color: #D84315; font-weight: 800; }

    /* --- è©¦é©—æŒ‰éˆ•ï¼šæ·±è‰²å­—é«” (#1A1A1A)ã€é«˜å°æ¯”æ·ºåº•è‰² --- */
    .stPopover button { 
        font-weight: 900 !important; font-size: 12px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    /* è—¥å» èƒŒæ™¯é…è‰² (æ·ºè‰²ç³»ä»¥çªé¡¯æ·±è‰²æ–‡å­—) */
    .stPopover button[aria-label*="Eli Lilly"] { background: #FCE4EC !important; border-left: 5px solid #E91E63 !important; } 
    .stPopover button[aria-label*="Daiichi Sankyo"] { background: #E8F5E9 !important; border-left: 5px solid #4CAF50 !important; } 
    .stPopover button[aria-label*="MSD"] { background: #E3F2FD !important; border-left: 5px solid #1976D2 !important; } 
    .stPopover button[aria-label*="AstraZeneca"] { background: #F3E5F5 !important; border-left: 5px solid #8E24AA !important; } 
    .stPopover button[aria-label*="GSK"] { background: #FFF3E0 !important; border-left: 5px solid #F57C00 !important; } 
    .stPopover button[aria-label*="Gilead"] { background: #E1F5FE !important; border-left: 5px solid #03A9F4 !important; } 
    .stPopover button[aria-label*="Seagen"] { background: #EEEEEE !important; border-left: 5px solid #212121 !important; } 

    /* æ·±åº¦æ•¸æ“šçœ‹æ¿ */
    .detail-section { background: white; border-radius: 18px; padding: 25px; margin-top: 10px; border: 1px solid #CFD8DC; }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 50px !important; font-weight: 900; color: #D84315; }
    .pharma-badge { background: #37474F; color: white; padding: 4px 15px; border-radius: 50px; font-size: 13px; font-weight: 700; display: inline-block; margin-bottom: 8px; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å¤§ç¶±ï¼šå­å®®å…§è†œç™Œ NSMP æ·±åº¦å¯¦è­‰è£œå®Œ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "POLEmut (è¶…çªè®Šå‹)", "content": "é å¾Œæœ€ä½³æ—ç¾¤ã€‚æ—©æœŸ (I-IIæœŸ) å»ºè­°è€ƒæ…®æ²»ç™‚é™éš (De-escalation)ï¼Œå¯é¿å…æ”¾åŒ–ç™‚å¼•èµ·ä¹‹é•·æœŸä½µç™¼ç—‡ã€‚"},
            {"title": "MMRd / MSI-H", "content": "å…ç–«é«˜åº¦æ•æ„Ÿã€‚æ™šæœŸä¸€ç·šæ–¹æ¡ˆï¼šChemo + PD-1 (GY018/RUBY) é¡¯è‘—æ”¹å–„ OSï¼Œæ¥çºŒ PD-1 æŒçºŒç¶­æŒã€‚"},
            {"title": "p53abn (Copy-number high)", "content": "ä¾µè¥²æ€§æœ€å¼·ã€å¾©ç™¼é¢¨éšªæœ€é«˜ã€‚æ—©æœŸäº¦éœ€ç©æ¥µå‡ç´šæ²»ç™‚ (å¦‚åŒ–æ”¾ç™‚ä½µç”¨)ï¼›Serous äºå‹éœ€æª¢æ¸¬ HER2 è©•ä¼°æ¨™é¶ä»‹å…¥ã€‚"},
            {"title": "NSMP (No Specific Molecular Profile)", "content": "<span class='tag-nsmp'>åˆ¤å®šæº–å‰‡ï¼šIHC MMR Intact / p53 wt / POLE å®šåºç„¡è‡´ç—…çªè®Šã€‚</span><br>1. <span class='tag-highlight'>é å¾Œåˆ†å±¤:</span> æ­¤äºå‹ç•°è³ªæ€§æœ€é«˜ï¼Œéœ€çµåˆ ER ç‹€æ…‹ã€Grade èˆ‡æ˜¯å¦å…·å‚™é¡¯è‘— LVSI é€²è¡ŒåŠ æ¬Šã€‚<br>2. <span class='tag-highlight'>è‡¨åºŠç­–ç•¥:</span> NSMP ä¼´éš¨ ER-negative æˆ– Grade 3 ç‚ºé«˜é¢¨éšªï¼›ER-positive ä¸”é€²å±•è¼ƒæ…¢è€…ï¼Œå¯è€ƒæ…®è·çˆ¾è’™æ²»ç™‚ (AI/Progestin) ä½œç‚ºåºåˆ—æˆ–è¼”åŠ©æ–¹æ¡ˆã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "é‡å°æ™šæœŸ/å¾©ç™¼ä¸€ç·šå®Œæˆå«é‰‘åŒ–ç™‚ä½µç”¨å…ç–«å¾Œï¼Œå»¶çºŒä½¿ç”¨ Pembro æˆ– Dostarlimab ç›´è‡³é€²å±•ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "MMRd / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥å…·é«˜æ‡‰ç­”æ·±åº¦ã€‚"}, {"title": "pMMR / NSMP", "content": "æ¨™æº–äºŒç·šæ–¹æ¡ˆï¼šPembrolizumab + Lenvatinib (SoC)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒç•¶å‰æœ‰æ•ˆä¹‹æ¨™é¶æˆ–å…ç–«æ²»ç™‚ç›´è‡³ç–¾ç—…é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carboplatin/Paclitaxel x6 Â± Bevacizumab"},
            {"title": "Mucinous (MOC) é‘‘åˆ¥", "content": "1. <span class='tag-highlight'>é‘‘å®š:</span> CK7+/SATB2- (åŸç™¼) æ’é™¤èƒƒè…¸è½‰ç§»ã€‚2. <span class='tag-highlight'>Expansile:</span> é å¾Œä½³ã€‚3. <span class='tag-highlight'>Infiltrative:</span> é«˜å¾©ç™¼é¢¨éšªã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutated", "content": "Olaparib å–®è—¥æˆ– Olaparib+Bev (è‹¥ä¸€ç·šå·²å«Bev)"},
            {"title": "HRD positive (wt)", "content": "å„ªå…ˆé¸ç”¨ Olaparib+Bev æˆ– Niraparib å–®è—¥ç¶­æŒ"},
            {"title": "HRD negative / pHRD", "content": "æœ‰ç”¨Bevå‰‡çºŒç”¨ï¼›æœªç”¨å‰‡è§€å¯Ÿæˆ–è©•ä¼° Niraparib ç²ç›Š"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC / PROC åˆ†æµ", "content": "ä¾ PFI å€åˆ†ã€‚æ¨™é¶çœ‹ç”Ÿç‰©æ¨™è¨˜ï¼šFRÎ± (Elahere) æˆ– HER2 ç‹€æ…‹ã€‚"},
            {"title": "MOC æ™šæœŸ/å¾©ç™¼", "content": "åŒ–ç™‚æŠ—æ€§å¼·ã€‚è€ƒæ…® GI-like æ–¹æ¡ˆã€Trial æˆ–æŠ— HER2 ç­–ç•¥ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒæ²»ç™‚ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [{"title": "Primary Protocols", "content": "Surgery(æ—©æœŸ), CCRT(LA), Pembro+ChemoÂ±Bev(è½‰ç§»)"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Metastatic IO Maint", "content": "è½‰ç§»æ€§æ–¹æ¡ˆå¾Œå»¶çºŒ Pembro ç¶­æŒç›´åˆ° PD"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "2L / 3L Therapy", "content": "Tisotumab vedotin (Tivdak) æˆ– Cemiplimab"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "åŒä¸€ç·šæœ‰æ•ˆæ–¹æ¡ˆæŒçºŒçµ¦è—¥ç›´è‡³é€²å±•"}]}
    ]
}

# --- 2. æ·±åº¦è‡¨åºŠè©¦é©—è³‡æ–™åº« (8 æ ¸å¿ƒ æ¥µé‡åŒ–æ•¸æ“š) ---
if 'trials_db' not in st.session_state:
    st.session_state.trials_db = [
        {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PSOC", "PROC"], 
         "rationale": "æ¨™é¶ FRÎ± ADCã€‚è¯ç”¨ Bevacizumab å¯ç”¢ç”Ÿè¡€ç®¡èª¿ç¯€å”åŒä½œç”¨ï¼Œè§£æ±º PARPi è€è—¥å¾Œæˆ– MOC æ—ç¾¤ä¹‹éœ€æ±‚ã€‚",
         "dosing": {"Exp": "LY4170156 3mg/kg + Bev 15mg/kg Q3W", "Control": "TPC / Platinum doublet + Bev"},
         "outcomes": {"ORR": "35-40%", "mPFS": "ä¸»è¦çµ‚é»", "HR": "Phase 3 é€²è¡Œä¸­", "CI": "NCT06536348", "AE": "Proteinuria"},
         "inclusion": ["HG Serous / Carcinosarcoma / MOC", "FRÎ± Expression Positive", "ç¬¦åˆåˆ†çµ„ PFI é™åˆ¶"],
         "exclusion": ["å…ˆå‰ç”¨é Topo I ADC", "ILD/è‚ºè‡Ÿç‚ç—…å²"], "ref": "ClinicalTrials.gov"},
        
        {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd (5.6 mg/kg)", "pos": "R-TX", "sub_pos": ["PROC"], 
         "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œå…·å‚™å¼·å¤§æ—è§€è€…æ•ˆæ‡‰ã€‚èƒ½å…‹æœé«˜åº¦ç•°è³ªæ€§çš„ PROC è…«ç˜¤ç’°å¢ƒã€‚",
         "dosing": {"Exp Arm": "R-DXd 5.6mg/kg IV Q3W", "Control Arm": "TPC (Paclitaxel/PLD/Topotecan)ã€‚"},
         "outcomes": {"ORR": "46.0%", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025", "AE": "ILD Risk"},
         "inclusion": ["PROC åµå·¢ç™Œ", "æ›¾æ¥å— 1-4 ç·š", "éœ€æ›¾ç”¨é Bevacizumab"],
         "exclusion": ["Low-grade è…«ç˜¤", "LVEF < 50%"], "ref": "JCO 2024"},
        
        {"cancer": "Ovarian", "name": "TroFuse-021 (MK-2870)", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": ["HRD negative / Unknown"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚çµåˆ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°çš„ ICD æ•ˆæ‡‰ï¼Œå„ªåŒ– pHRD æ—ç¾¤åœ¨ä¸€ç·šç¶­æ™‚ç²ç›Šã€‚",
         "dosing": {"Arm 1": "Sac-TMT å–®è—¥", "Arm 2": "Sac-TMT + Beva 15mg/kg", "Arm 3": "Observation/Beva"},
         "outcomes": {"ORR": "Est 40%", "mPFS": "æ‹›å‹Ÿä¸­", "HR": "Phase 3", "CI": "NCT06241729", "AE": "å£è…”ç‚, è…¹ç€‰"},
         "inclusion": ["æ–°è¨ºæ–· FIGO III/IV", "HRD negative (pHRD)", "1Lå«é‰‘å¾Œ CR/PR"],
         "exclusion": ["BRCA çªè®Šæˆ– HRD é™½æ€§", "å…ˆå‰ç”¨é Trop-2 ADC"], "ref": "ENGOT-ov85"},
        
        {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": ["IO Maintenance", "MMRd", "NSMP"], 
         "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ PD-1ã€‚é€éå…ç–«èª¿ç¯€å¼·åŒ– Pembrolizumab åœ¨ pMMR æˆ– NSMP æ—ç¾¤çš„é•·æœŸæ‡‰ç­”ã€‚",
         "dosing": {"Maintenance": "Pembro 400 mg Q6W + Sac-TMT 5 mg/kg Q6Wã€‚"},
         "outcomes": {"ORR": "Est 35%", "mPFS": "Phase 3", "HR": "Ongoing", "CI": "NCT06132958", "AE": "è²§è¡€, å£è…”ç‚"},
         "inclusion": ["pMMR å­å®®å…§è†œç™Œ", "FIGO III/IV ä¸€ç·šå«é‰‘+Pembroå¾Œé” CR/PR"],
         "exclusion": ["å…ˆå‰æ¥å—éæ™šæœŸç³»çµ±æ€§ IO æ²»ç™‚", "å­å®®è‚‰ç˜¤"], "ref": "ESMO 2025"},
        
        {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["pMMR", "p53abn", "NSMP"], 
         "rationale": "æ¨™é¶ Trop-2 ADCã€‚åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡èˆ‡å…ç–«å¤±æ•—å¾Œä¹‹æ•‘æ´ã€‚",
         "dosing": {"Exp": "Sacituzumab Govitecan 10mg/kg (D1, D8 Q21D)", "Control": "TPC (Doxo/Taxel)ã€‚"},
         "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727", "AE": "å—œä¸­æ€§çƒæ¸›å°‘"},
         "inclusion": ["å¾©ç™¼æ€§ EC (éè‚‰ç˜¤)", "é‰‘é¡èˆ‡ PD-1 å¤±æ•—å¾Œé€²å±•"],
         "exclusion": ["å…ˆå‰ç”¨é Trop-2 ADC", "æ´»å‹•æ€§ CNS è½‰ç§»"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive"], 
         "rationale": "æ¨™é¶ HER2 ADCã€‚æ•‘æ´åŒ–ç™‚ç©©å®šå¾Œä¹‹ç¶­æŒé¦–é¸ã€‚è¶…é«˜ DAR å„ªå‹¢èƒ½æœ‰æ•ˆæ®ºå‚· HER2 è¡¨ç¾ç™Œç´°èƒã€‚",
         "dosing": {"Standard": "T-DXd 5.4mg/kg IV Q3W", "Combo": "T-DXd + Beva 15mg/kgã€‚"},
         "outcomes": {"ORR": "46.3% (IHC 3+)", "mPFS": "10.4m", "HR": "0.42", "CI": "NCT04482309", "AE": "ILD Risk"},
         "inclusion": ["HER2 IHC 1+/2+/3+", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)"],
         "exclusion": ["ILD è‚ºéƒ¨ç—…å²", "LVEF < 50%"], "ref": "JCO 2024"},

        {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Beva", "pos": "R-TX", "sub_pos": ["PROC"], 
         "rationale": "é‡å°é€æ˜ç´°èƒç™Œ (OCCC)ã€‚PD-1 + VEGF é›™é‡é˜»æ–·æ”¹å–„å¾®ç’°å¢ƒã€‚",
         "dosing": {"Combo": "Dostarlimab + Bev Q3W", "Control": "Chemo (Gem/PLD/Taxel)ã€‚"},
         "outcomes": {"ORR": "40.2%", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862", "AE": "é«˜è¡€å£“"},
         "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)"],
         "exclusion": ["å…ˆå‰ç”¨éä»»ä½•å…ç–«æ²»ç™‚"], "ref": "JCO 2025"},

        {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak", "pos": "R-TX", "sub_pos": ["2L / 3L Therapy"], 
         "rationale": "æ¨™é¶ Tissue Factor (TF) ADCã€‚æ—¨åœ¨å…‹æœå¾Œç·šå­å®®é ¸ç™ŒåŒ–ç™‚è€è—¥æ€§ã€‚",
         "dosing": {"Exp Arm": "Tisotumab vedotin 2.0mg/kg Q3W", "Control Arm": "Chemo (TPC)ã€‚"},
         "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70", "CI": "NEJM 2024", "AE": "çœ¼è¡¨æ¯’æ€§"},
         "inclusion": ["å¾©ç™¼/è½‰ç§»å­å®®é ¸ç™Œ", "å…ˆå‰ 1â€“2 ç·šæ²»ç™‚å¾Œé€²å±•"],
         "exclusion": ["åš´é‡çœ¼ç–¾/è§’è†œç‚"], "ref": "NEJM 2024"}
    ]

# --- 3. å´é‚Šæ¬„ï¼šAI åŠŸèƒ½ (ä¿®æ­£æ¨¡å‹åç¨±) ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = st.session_state.trials_db[0]['name']

with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI è‡¨åºŠåª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥ç—…æ­· (å«åˆ†å­æ¨™è¨˜)", height=250, placeholder="ä¾‹ï¼š62y/o EC, NSMP, ER-negative...")
        if st.button("ğŸš€ é–‹å§‹è‡¨åºŠåˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    # ä¿®æ­£ï¼šä½¿ç”¨ gemini-1.5-flash ä»¥ç¢ºä¿ API ç›¸å®¹æ€§
                    model = genai.GenerativeModel('gemini-1.5-flash')
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚åƒè€ƒè©¦é©—ï¼š{st.session_state.trials_db}ã€‚è«‹ä¾æ“š FIGO 2023 æˆ– MOC é‚è¼¯æä¾›å»ºè­°ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 4. ä¸»é é¢ï¼šæ¥µè‡´ç·Šæ¹Šå°èˆªå„€è¡¨æ¿ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªå„€è¡¨æ¿ (2026 SoC & Molecular)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šé»æ“Šå½©è‰²æ¨™è¨˜æŸ¥çœ‹äº®é» (SoC èˆ‡è©¦é©—å°æ‡‰)")
cols = st.columns(4)
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            relevant_trials = [t for t in st.session_state.trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            if relevant_trials:
                for t in relevant_trials:
                    label = f"{t['pharma']} | {t['name']} | {t['drug']}"
                    ukey = f"btn_{t['name']}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    with st.popover(label, use_container_width=True):
                        st.markdown(f"#### âœ¨ {t['name']} è‡¨åºŠè§£æ")
                        st.info(f"**Rationale:** {t['rationale'][:160]}...")
                        if st.button("ğŸ“Š é–‹å•Ÿæ·±åº¦åˆ†æå ±å‘Š", key=ukey):
                            st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 5. æ·±åº¦åˆ†æçœ‹æ¿ ---
st.divider()
t_options = [t["name"] for t in st.session_state.trials_db if t["cancer"] == cancer_type]
try: curr_idx = t_options.index(st.session_state.selected_trial)
except: curr_idx = 0

if t_options:
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›è©³ç´°è©¦é©—å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in st.session_state.trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<span class='pharma-badge'>{t['pharma']}</span>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1, r2 = st.columns([1.3, 1])
    with r1:
        st.markdown("<div class='info-box-blue' style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰å¯¦è­‰ (Rationale):** {t['rationale']}")

    with r2:
        st.markdown("<div class='info-box-gold' style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Efficacy & Outcomes</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div class='hr-display' style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
                <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Hazard Ratio (HR) / NCT ID</div>
                <div class='hr-big-val'>{t['outcomes']['HR']}</div>
                <div class='hr-ci' style='font-size:18px; color:#5D4037; font-weight:700;'>{t['outcomes']['CI']}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes']['ORR']} | **mPFS:** {t['outcomes']['mPFS']}")
        st.error(f"**Safety / AE:** {t['outcomes']['AE']}")

    st.divider()
    r3, r4 = st.columns(2)
    with r3:
        st.markdown("<div class='info-box-blue' style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (ç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for inc in t['inclusion']: st.write(f"â€¢ **{inc}**")
    with r4:
        st.markdown("<div class='info-box-blue' style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (æ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
        for exc in t['exclusion']: st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
